Literature DB >> 12042281

Increased (CTG/CAG)(n) lengths in myotonic dystrophy type 1 and Machado-Joseph disease genes in idiopathic azoospermia patients.

Huichin Pan1, Yet-Young Li, Tung-Cheng Li, Wen-Tin Tsai, Shuan-Yow Li, Kuang-Ming Hsiao.   

Abstract

BACKGROUND: An increase in CAG trinucleotide repeat length in the androgen receptor (AR) gene has been linked to idiopathic azoospermia.
METHODS: In order to test whether other (CAG/CTG)(n) loci are also affected, the (CAG/CTG)(n) frequency distribution at myotonic dystrophy type 1 (DM1), Machado-Joseph disease (MJD), dentatorubral-pallidoluysian atrophy (DRPLA) and spinocerebellar ataxia type 8 (SCA8) loci, in addition to the AR gene, was investigated in 48 azoospermia patients and 47 controls.
RESULTS: The median CAG repeat length in the AR gene was significantly longer in azoospermia patients than in controls (23 versus 21, P < 0.001). Significant differences were also noted in the upper tails of trinucleotide repeat length distributions at both DM1 and MJD loci between the two populations. At the DM1 locus, alleles of more than 18 repeats were observed only in azoospermia patients, and not in controls (P = 0.014). At the MJD locus, the frequency of normal alleles (ANs) with 29 or more CAG repeats was also much higher in azoospermia patients (29.2 versus 7.4%; P = 0.0001). However, the repeat length distribution at DRPLA and SCA8 loci did not differ in the two groups.
CONCLUSIONS: These data indicated that, at least in a subset of azoospermia patients, there was an increase in the number of trinucleotide repeats in some disease loci. Thus, it is noteworthy to evaluate whether offspring of these azoospermia patients, if born by assisted reproductive technologies, have an increased risk of trinucleotide repeat diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12042281     DOI: 10.1093/humrep/17.6.1578

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  Infertile Males with Muscle Weakness: Keep Your Eyes Open for Myotonic Dystrophy.

Authors:  Partha P Chakraborty; Sugata N Biswas; Shinjan Patra; Gouranga Santra
Journal:  J Obstet Gynaecol India       Date:  2016-05-03

2.  Myotonic dystrophy type 1 presenting as male infertility.

Authors:  Woong Bin Kim; Ji Yun Jeong; Seung Whan Doo; Won Jae Yang; Yun Seob Song; Seung Ryul Lee; Ji Woong Park; Dong Won Kim
Journal:  Korean J Urol       Date:  2012-02-20

Review 3.  Mendelian genetics of male infertility.

Authors:  Kathleen Hwang; Alexander N Yatsenko; Carolina J Jorgez; Sarmistha Mukherjee; Roopa Lata Nalam; Martin M Matzuk; Dolores J Lamb
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

4.  Expansion of CAG repeats in the spinocerebellar ataxia type 1 (SCA1) gene in idiopathic oligozoospermia patients.

Authors:  Yen-Chein Lai; Wen-Chung Wang; Jiann-Jou Yang; Shuan-Yow Li
Journal:  J Assist Reprod Genet       Date:  2009-07-14       Impact factor: 3.412

5.  Genetic Association Between Androgen Receptor Gene CAG Repeat Length Polymorphism and Male Infertility: A Meta-Analysis.

Authors:  Bihui Pan; Rui Li; Yao Chen; Qiuqin Tang; Wei Wu; Liping Chen; Chuncheng Lu; Feng Pan; Hongjuan Ding; Yankai Xia; Lingqing Hu; Daozhen Chen; Jiahao Sha; Xinru Wang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

6.  Androgen receptor (AR)-CAG trinucleotide repeat length and idiopathic male infertility: a case-control trial and a meta-analysis.

Authors:  Narges Mobasseri; Faezeh Babaei; Mohammad Karimian; Hossein Nikzad
Journal:  EXCLI J       Date:  2018-12-17       Impact factor: 4.068

Review 7.  Cellular Senescence and Aging in Myotonic Dystrophy.

Authors:  Yuhei Hasuike; Hideki Mochizuki; Masayuki Nakamori
Journal:  Int J Mol Sci       Date:  2022-02-20       Impact factor: 5.923

Review 8.  Muscle wasting in myotonic dystrophies: a model of premature aging.

Authors:  Alba Judith Mateos-Aierdi; Maria Goicoechea; Ana Aiastui; Roberto Fernández-Torrón; Mikel Garcia-Puga; Ander Matheu; Adolfo López de Munain
Journal:  Front Aging Neurosci       Date:  2015-07-09       Impact factor: 5.750

Review 9.  Targeting Myotonic Dystrophy Type 1 with Metformin.

Authors:  Mikel García-Puga; Ander Saenz-Antoñanzas; Ander Matheu; Adolfo López de Munain
Journal:  Int J Mol Sci       Date:  2022-03-07       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.